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Background
Normalised left ventricular mass (LVM) is a powerful
prognostic tool. Traditionally, normalising has been
achieved by indexing LVM to body surface area (BSA). A
recent ‘Multiethnic Study of Atherosclerosis’ (MESA)
sub-study demonstrated indexing LVM to height1.7 is
more sensitive at identifying left ventricular hypertrophy
(LVH) associated with cardiovascular events and all-cause
death. We evaluated the ability of the ECG, an universal
investigation in patients with hypertension, to detect
LVH defined traditionally by LVM/BSA and by the prog-
nostically more important LVM/height1.7 method using
CMR (non-invasive gold-standard for LVM).
Methods
111 consecutive patients (mean age: 52.1±14.4 years, 51.4%
male) from our tertiary hypertension clinic who under-
went CMR were included. LVM was estimated using
established CMR methods. Papillary muscles were
included in LVM, using blood thresholding contouring
software. LVH was defined as >95% confidence interval of
normal references values for LVM/BSA and for LVM/
height1.7 respectively. A contemporaneous 12-lead ECG
was assessed, by a clinician blinded to CMR data, for the
following LVH criteria: Gubner-Ungerleider, Sokolow-
Lyon voltage, Sokolow-Lyon product, Cornell voltage,
Cornell product, Romhilt-Estes 4-point and 5-point. Sensi-
tivity, specificity, positive predictive valve (PPV), negative
predictive value (NPV), and accuracy were calculated.
Area under the receiver operator curve analysis (ROC-
AUC) was performed.
Results
LVH was present in 43.2% by LVM/BSA and 32.4% by
LVM/height1.7. There was no consistent trend in ROC-
AUC values for detecting LVH as defined by LVM/
height1.7 compared to LVM/BSA (Figure 1). The highest
sensitivity (56%) was achieved by Gubner-Ugerleider and
Cornell product) and the highest specificity (91%) by
Sokolow-Lyon product for LVM/height1.7. Combining
ECG criteria improved these sensitivities and specificities;
if Gubner-Ugerleider or Cornell product were positive,
sensitivity increased to 75% (accuracy 65%) and if both
Sokolow-voltage product and Cornell voltage were nega-
tive, specificity increased to 99% (accuracy 71%).
Subgroup analysis by gender (Figure 2) revealed higher
maximal sensitivity for men (77% by Romhilt-Estes 5-
point) compared to women (67% by Gubner-Ugerleider)
but lower maximal specificity for men (93% by Sokolow-
Lyon product and Cornell voltage) compared to women
(100% by Sokolow-Lyon product). There was a trend
towards higher ROC-AUC values for women compared
to men.
Conclusions
Relative to CMR, standard 12-lead ECG criteria of LVH
have a wide range of predictive values (but consistently
greater specificity than sensitivity) in a tertiary hyperten-
sion clinic setting with high LVH prevalence. The poor
diagnostic accuracy at detecting prognostically significant
LVH highlights the ECG’s limitations as a screenign tool
for cardiac end-organ damage in hypertension. Combining
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ECG criteria and using different criteria for men and
women improve the ECG’s performance.
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Figure 1 Predictive values for ECG-LVH criteria to detect CMR-LVH.
Figure 2 Subgroup analysis by gender.
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